Home
Opinion Formers
Breast Cancer Care
Breast Cancer Care: Reaction to NICE recommendation on bevacizumab (Avastin)

Breast Cancer Care: Reaction to NICE recommendation on bevacizumab (Avastin)

Wednesday, 23 February 2011 12:00 AM

Commenting on NICE's recommendation on bevacizumab (Avastin), Dr Emma Pennery, Clinical Director at Breast Cancer Care said:

"This recommendation will be disappointing for people with secondary (metastatic) breast cancer.

1

"We know from supporting these patients via our helpline and other services how much they value any additional treatments that have the potential to help slow down the progression of the disease.

"We would like to see further research that clearly identifies which patients will benefit from bevacizumab and the most effective way to use it in combination with other drugs. "In the mean time, doctors who believe their patients could benefit from bevacizumab can apply for funding through the Cancer Drugs Fund and we encourage them to discuss this option."

ENDS

Notes to editors:

1) A diagnosis of advanced or secondary breast cancer means that the breast cancer cells have travelled to another part of the body such as the liver, lungs or bones. Secondary breast cancer is not curable but thanks to advances in medical treatments the disease can be controlled for many months and in some cases years.

For further media information, please contact
Laura Grossart
0207 960 3473/ 0770 290 1334
Laura.Grossart@breastcancercare.org.uk

Breast Cancer Care is here for anyone affected by breast cancer. We bring people together, provide information and support, and campaign for improved standards of care. We use our understanding of people's experience of breast cancer and our clinical expertise in everything we do.Visit www.breastcancercare.org.uk or call our free helpline on 0808 800 6000.

Disclaimer: Press releases published on this page are from key opinion formers who promote their organisation's activities by subscribing to a campaign site within politics.co.uk. politics.co.uk does not endorse, edit, or attempt to balance the opinions expressed on this page. The content of press releases are wholly the responsibility of the originating company or organisation.

Comment: Breast cancer screenings are worth the cost

Pennery sits on various expert management groups for UK and European breast cancer research.

Breast cancer screening saves live and is worth the cost, despite the health department’s findings.

comments

Breast cancer cases 'on the increase'

Watchdog approves breast cancer drug

Nice approves use of Herceptin in early stage breast cancer sufferers

Thousands of women will have access to a life-saving new drug on the NHS after the health watchdog today approved Herceptin for use against early stage breast cancer.

Fears for future of breast cancer services

Healthy living 'delays breast cancer'

Over-50s 'unaware' of increased breast cancer risk

Trial launched to tackle breast cancer

New drugs cocktail gives hope to breast cancer sufferers

UK 'lagging behind' on cancer care

The government has been forced to defend its cancer care after research claimed investment is not matched by results.

Labour promises to cut breast cancer waiting time

Tony Blair today promised to cut cancer waiting times in a third term Labour government.

Opinion Formers

Press Releases

BASC: NI firearms dealers discuss fees increase proposals

Breast Cancer Care responds to MPs' rejection of House of Loards amendments to the Welfare Reform Bill

Breast Cancer Care: Valuing Older Women

Breast Cancer Care launches policy briefing: Improving outcomes and experiences for older women with breast cancer

Breast Cancer Care: Reaction to NICE recommendation on bevacizumab (Avastin)

Breast Cancer Care on research published in the Lancet Oncology online

Breast Cancer Care: BMJ research on UK breast cancer mortality rates

Breast Cancer Care reaction to White Paper

Breast Cancer Care - discrimination of treatment in older women with breast cancer

Breast Cancer Care nominated for national award

Twitter

Join the conversation at #opinion_formers

Related Opinion Former Press Releases

Breast Cancer Care reaction to White Paper

Commenting on the publication of the coalition government's NHS white paper today, Samia al Qadhi, Chief Executive of Breast Cancer Care said.

Breast Cancer Care: Valuing Older Women

Breast Cancer Care is publishing recommendations on how to improve outcomes and experiences for older women with breast cancer in a new policy briefing, supported by Age UK.

Breast Cancer Care launches policy briefing: Improving outcomes and experiences for older women with breast cancer

Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.

Special event coverage

Festival of Social Sciences: Celebrating the Social Sciences

Evidence-based policy should not be a radical concept. It needs to be celebrated.

Festival of Social Sciences: 2 languages: 2 brains, 2 minds, 2 cultures?

As part of the ESRC Festival of Social Sciences, the Deafness Cognition And Language Research Centre (DCAL) hosted an event exploring the powerful benefits of bilingualism in spoken and sign languages, for hearing and deaf people alike - benefits that reach hearing and deaf people alike.

Opinion Former Events

15

BSIA: Information Destruction Exhibition & Conference 2013

Following the great success of the BSIA's Information Destruction Conference and Exhibition in May 2012, we are pleased to annouce that the event is returning again in June 2013. This one-day conference and exhibition is aimed at key decision makers in organisations that carry out the secure destruction of confidential material.